Raffles Medical Group Ltd (RAFLF) Research

Raffles Medical Group Ltd (RMG) is an integrated private healthcare provider with its main operations spanning Singapore, Greater China, Vietnam, Cambodia, and Japan. The company structures its diverse activities across three core segments: Healthcare Services, Hospital Services, and Investment Holdings. Its flagship institution, Raffles Hospital, functions as a tertiary care facility offering a wide spectrum of specialized medical services. These include comprehensive care in oncology, pediatrics, women's health, traditional Chinese medicine, counseling, dentistry, and critical treatments such as dialysis, diabetes, and endocrinology. Further offerings encompass ear, nose, and throat care, ophthalmology, fertility treatments, cardiology, internal medicine, neuroscience, pain management, rehabilitation, orthopedics, dermatology and aesthetics, surgery, nuclear medicine, and urology. Beyond the hospital's extensive offerings, RMG also provides urgent care services, general practice medicine, comprehensive health screening programs, and various multi-disciplinary specialist clinic options. Additionally, the company is engaged in the commerce of pharmaceuticals, nutraceuticals, and diagnostic equipment. It also extends its expertise through advisory and consulting services, develops innovative IT solutions, and undertakes research and experimental development in biotechnology, life sciences, and medical science. Founded in Singapore in 1976, Raffles Medical Group Ltd operates as a subsidiary under Raffles Medical Holdings Pte. Ltd.

Open Raffles Medical Group Ltd (RAFLF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.